Anthrax AV7909 Boost Evaluation Study
Condition: Anthrax Interventions: Biological: AV7909 Full Dose (0.5 mL); Biological: AV7909 Half Dose (0.25 mL) Sponsors: Biomedical Advanced Research and Development Authority; Rho Federal Systems Division, Inc.; ICON plc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials
Emergent BioSolutions Announces FDA Acceptance of Biologics License Application for AV7909 Anthrax Vaccine Candidate
GAITHERSBURG, Md., June 24, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the U.S. Food and Drug Administration (FDA) accepted for review the Biologics License Application (BLA) for AV7909 (Anthrax Vaccine... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - June 24, 2023 Category: Pharmaceuticals Source Type: clinical trials
Evaluation of the SRI B. Anthracis Lethal Factor Diagnostic System
Condition: Anthrax Intervention: Diagnostic Test: Anthrax LF Dx System Sponsors: SRI International; Department of Health and Human Services Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2023 Category: Research Source Type: clinical trials